Trial intelligence / Profile preview

Long-term antibiotic therapy in stable COPD

2011-001063-43Phase 3Terminated

Sponsor
University College London
Start
Sep 2011
Modality
Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules
Countries
1
01

Overview

A Phase 3 trial of moxifloxacin, azithromycin, doxycycline in chronic obstructive pulmonary disease (COPD), sponsored by University College London. Started Sep 2011; status: terminated.

02

Drugs

moxifloxacinazithromycindoxycycline
03

Conditions

chronic obstructive pulmonary disease (COPD)

Beyond the preview

Go deeper on 2011-001063-43.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2011-001063-43.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call